S. 369 - Preserve Access to Affordable Generics Act
- Sponsor:
- Herb Kohl
- Summary:
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
Preserve Access to Affordable Generics Act
S. 369 — 111th Congress (2009–2010)
- Summary
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
- Other Titles
- Preserve Access to Affordable Generics Act
- Preserve Access to Affordable Generics Act
- Sponsor
- Herb Kohl
- Co-Sponsors
- Subjects
- Commerce
- Administrative law and regulatory procedures
- Competition and antitrust
- Contracts and agency
- Federal Trade Commission (FTC)
- Intellectual property
- Marketing and advertising
- Prescription drugs
- Related Bills
- Major Actions
Introduced 2/03/2009 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 2/03/2009 2/03/2009 Sponsor introductory remarks on measure. (CR S1433) 2/03/2009 Read twice and referred to the Committee on the Judiciary. Put on a legislative calendar 10/15/2009 Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. 10/15/2009 Committee on the Judiciary. Reported by Senator Leahy with an amendment in the nature of a substitute. Without written report. Put on a legislative calendar 10/15/2009 Placed on Senate Legislative Calendar under General Orders. Calendar No. 183. 2/02/2010 By Senator Leahy from Committee on the Judiciary filed written report. Report No. 111-123. Minority views filed. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
supported this bill
Elderly issues/Social Security |
Consumer groups |
Pharmaceutical manufacturing (split) |
opposed this bill
Pharmaceutical manufacturing (split) |
Contributions data source: OpenSecrets.org